In Re: TALC Product Liability Litigation

CourtSuperior Court of Delaware
DecidedSeptember 10, 2018
DocketN17C-03-054 TAL
StatusPublished

This text of In Re: TALC Product Liability Litigation (In Re: TALC Product Liability Litigation) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re: TALC Product Liability Litigation, (Del. Ct. App. 2018).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

IN RE: C.A. No. Nl 7C-O3-054 TAL TALC PRODUCT

LIABILITY LITIGATION

Submitted: July 30, 2018 Decided: September 10, 2018

OPINION

Defendants Johnson & Johnson and Johnson & Johnson Consumer Inc. ’s Motion to Dz'smiss Based on Lack ofPersonal Jurisdiction. GRANTED.

Defena’ants Johnson & Johnson and Johnson & Johnson Consumer Inc. 's Motionfor a Protective Order to Quash Jurisdictional Discovery Requests. GRANTED.

R. Joseph Hrubiec, Esquire and W. Steven Berman, Esquire, NAPOLI SHKOLNIK, LLC, Wilmington, Delaware. Hunter J. Shkolnik, Esquire, NAPOLI SHKOLNIK, PLLC, Melville, NeW York. Attorneys for Plaintiffs.

Raeann Warner, Esquire, JACOBS & CRUMPLAR, P.A., Wilmington, Delaware. Attorney for Plaintiffs.

Michael P. Kelly, Esquire and Daniel J. Brown, Esquire, McCARTER & ENGLISH, LLP, Wilmington, Delaware. Jessica D. Miller, Esquire, SKADDEN, ARPS, SLATE, MEAGHER & FLOM, LLP, Washington, D.C. (argued). Attorneys for Defendants Johnson & Johnson and Johnson & Johnson Consumer Inc. (f/k/a Johnson & Johnson Consumer Companies, Inc.).

BUTLER, J.

INTRODUCTION

The Court is here presented with a host of Complaints, all to the same effect. Each alleges that Defendants, in various capacities, Were involved in the production, marketing, and sale of talc, specifically in the form of baby powder. It is alleged that this product, advertised as smooth and soothing to babies, causes cancer in adult Women. While multiple Defendants are named, only Johnson & Johnson and its subsidiary, Johnson & Johnson Consumer Inc. (f/k/a Johnson & Johnson Consumer Companies, Inc.) (collectively, “JNJ”), have moved to dismiss the claims brought by nonresident Plaintiffs for lack of personal jurisdiction JNJ also moves for a protective order, seeking to foreclose the nonresident Plaintiffs from taking “jurisdictional discovery.” After careful consideration, the Court finds that it is Without personal jurisdiction over JNJ as to the claims of the nonresident Plaintiffs. The Court further finds that the nonresident Plaintiffs have not set forth a plausible basis to believe that limited jurisdictional discovery Will establish the requisite

jurisdiction, and the Court Will therefore also grant JNJ’s Motion for a Protective

Order.

BACKGROUND

These complaints allege that women who use talcum powder in their perineal area over a period of time contracted ovarian cancer. Talc was manufactured, marketed, and sold by the defendants as baby powder.

Lawsuits making similar allegations have been filed in multiple jurisdictions across the United States. l In one such case in Missouri, Johnson & Johnson moved to dismiss a claim brought by a nonresident of Missouri on personal jurisdiction grounds. The motion to dismiss was denied by the trial court. But after a jury awarded the plaintiff $72 million in damages, a Missouri appellate court reversed the trial court’s personal jurisdiction ruling, effectively wiping out the verdict.2

Over 200 talc lawsuits have been filed in Delaware. The Plaintiffs in these

suits hail from all over the country.3 Two law firms represent all of the Plaintiffs in

l See Tiffany Hsu, Risk on All Sides as 4,800 Women Sue Over Johnson’s Baby Powder and Cancer, N.Y. Times (Sept. 28, 2017), illlp.~_~':t“/w\-v\-\-'.iwliliies.com;"£lll?fU‘J!ES»’busincssz"|ohnson- iind-ioIm.~;mi-bailw»lalc.'un'\-|)owclcr-Iaiw:»‘uitz~'.hlm|; Wornan Gets $417 Million Verdict From Johnson & Johnson in Baby Powder Cancer Suit, NBCNews.com (Aug. 22, 2017), Ii| l|)s:t_fi\-'\\-".-v.nbcnews.co\n!hcaill|ifhci-i|1Ii-no\-v.~';;’\-voman-gcl.~';-=l l 7~million-vci'tlici-iohnson~ iohnsol1~baby-po\-\»dcr-ciinccr-ii?‘~}¢l??`1; In re Johnson & Johnson Talcum Powder Cases, No. BC628228, 2017 WL 4780572 (Cal. Super. Ct. Oct. 20, 2017).

2 See Estate ofFox v. Johnson & Johnson, 539 S.W.3d 48 (Mo. Ct. App. 2017), rev ’g and vacating 2016 WL 799325 (Feb. 26, 2016), reh ’g and/or transfer denied (Dec. 19, 2017), transfer denied (Mar. 6, 2018).

3 See, e.g., Compl. 11 1, Weldon v. Johnson & Johnson, C.A. No. N18C-01-137 (Del. Super. filed Jan. 12, 2018) (Trans. I.D. 61563601) (Michigan); Compl. 11 1, Chappell v. Johnson & Johnson, C.A. No. N17C-12-294 (Del. Super. filed Dec. 21, 2017) (Trans. I.D. 61494847) (New York); Compl. 1[ 1, Anderson v. Johnson & Johnson, C.A. No. N17C-10-338 (Del. Super. filed Oct. 26, 2017) (Trans. I.D. 61288868) (Louisiana); Compl. 11 1, Chubb v. Johnson & Johnson, C.A. No.

these Delaware cases. The Complaints are substantively quite similar in their factual allegations and legal theories.

A. Plaintiffs’ Allegations

Plaintiffs allege that JNJ and the other named Defendants produced, marketed, sold, and shipped talc-based products over a number of years. They claim that this production and marketing persisted despite convincing evidence developed by studies that talc was associated with ovarian cancer when used by women on the perineum. Plaintiffs allege that JNJ and the other Defendants, acting individually, collectively and through industry councils and related lobbying efforts, mounted a concerted effort to avoid warning the public of the dangers associated with the use of talc. According to Plaintiffs, JNJ continued its sales and marketing campaign of talc products despite being explicitly advised of its dangers from several creditable sources.

B. JNJ’s Motion to Dismiss

JNJ has not filed an answer to the Complaint, arguing instead that the Court should dismiss the Complaints of nonresident plaintiffs because the Court has

neither “general” nor “specific” jurisdiction over JNJ. Plaintiffs also served JNJ

N17C-04-102 (Del. Super. filed Apr. 11, 2017) (Trans. I.D. 60455438) (Tennessee); Compl. 11 1, Gordon v. Johnson & Johnson, C.A. No. N16C-10-237 (Del. Super. filed Oct. 28, 2016) (Trans. I.D. 59762614) (North Carolina); Compl. 11 1, Worth v. Johnson & Johnson, C.A. No. N16C-10- 239 (Del. Super. filed Oct. 28, 2016) (Trans. I.D. 59762787) (Mississippi).

with a number of “jurisdictional discovery” requests intended to support the Court’s exercise of personal jurisdiction over JNJ. Rather than responding to the discovery, JNJ has filed a Motion for a Protective Order, seeking exemption from responding to the discovery demand because, as JNJ sees it, discovery will not yield facts that would support jurisdiction in Delaware.

C. Procedural History

At the Court’s request, Plaintiffs’ counsel first filed their opposition to JNJ’s Motion for a Protective Order. While this issue was under consideration, the United States Supreme Court handed down its decision in Bristol-Myers Squibb Co. v. Superior Court of California, San Francz'sco Coanty.4 The Court then invited the parties to file supplementary briefs on the impact of that decision.

After reviewing the briefing at that stage, it became clear that the jurisdictional discovery issue was completely intertwined with the question of jurisdiction itself. Plaintiffs then obliged the Court’s request to respond to the Motion to Dismiss as

well.5

4137 S. Ct. 1773 (U.S.) 2017.

5 Of the roughly 200 cases that have been filed in Delaware, a scant few_ approximately 12_- originally named an additional entity, OMJ Pharmaceuticals, lnc. (“OMJ”). This entity is a Johnson & Johnson subsidiary that is incorporated in Delaware. Shortly after it was named as a Defendant for the first time in 2016, OMJ moved to dismiss the case against it, but not for lack of jurisdiction. Rather, OMJ sought dismissal on grounds that it had simply been improperly named.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Helicopteros Nacionales De Colombia, S. A. v. Hall
466 U.S. 408 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Istituto Bancario Italiano SpA v. Hunter Engineering Co.
449 A.2d 210 (Supreme Court of Delaware, 1982)
Crescent/Mach I Partners, L.P. v. Turner
846 A.2d 963 (Court of Chancery of Delaware, 2000)
Werner v. Miller Technology Management, L.P.
831 A.2d 318 (Court of Chancery of Delaware, 2003)
Hart Holding Co. v. Drexel Burnham Lambert Inc.
593 A.2d 535 (Court of Chancery of Delaware, 1991)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Genuine Parts Co. v. Cepec
137 A.3d 123 (Supreme Court of Delaware, 2016)
Estate of Fox v. Johnson & Johnson
539 S.W.3d 48 (Missouri Court of Appeals, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
In Re: TALC Product Liability Litigation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-talc-product-liability-litigation-delsuperct-2018.